FDA Investigator: Andrew R. Wasko
- Andrew R. Wasko first started conducting FDA inspections in 2023, with the last inspection in 2024. Over that time, Andrew R. Wasko has conducted 10 inspections at 10 companies across 10 sites.
Get Andrew Wasko's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Altasciences Preclinical Seattle, Everett | Jul 2023
Available Now - $199
Andrew R. Wasko
Biologics Form 483
FDA 483 North American Science Associates, Northwood | 2023
Available Now - $199
Andrew R. Wasko
Human Drugs Form 483
FDA 483 ATTENTIVE SCIENCE LLC, Stilwell | 2024
Out-of-stock
Andrew R. Wasko
Human Drugs Form 483
FDA 483 Texas Biomedical Research Institute, San Antonio | 2024
Out-of-stock
Andrew R. Wasko
Human Drugs Form 483
FDA 483 Beijing Union-Genius Pharmaceutical Technology Development Co., Ltd., Beijing | 2024
Out-of-stock
Andrew R. Wasko
Human Drugs Form 483
FDA 483 Level Biotechnology Inc, New Taipei City | 2024
Out-of-stock
Andrew R. Wasko
Human Drugs Form 483
FDA 483 University of Texas Medical Branch, Galveston | 2023
Out-of-stock
Andrew R. Wasko
Human Drugs Form 483
Co-Investigators (11)
- Joanne M. Schlossin, FDA Investigator
- Hugh M. McClure, FDA Investigator
- Carmen Y. Fisher, FDA Investigator
- Zhou Chen, FDA Investigator
- Andrea A. Branche, FDA Investigator
- Audrey J. Yarbrough, FDA Investigator
- Byungja E. Marciante, FDA Investigator
- Julian C. Hanson, FDA Investigator
- Erin M. McDowell, FDA Investigator
- Grace P. Santos, FDA Investigator
- Craig T. Rybus, FDA Investigator